MedPath

EndoRings Colonoscopy for Adenoma Detection

Not Applicable
Conditions
Adenoma
Interventions
Device: EndoRings
Device: Standard colonoscopy
Registration Number
NCT03469622
Lead Sponsor
Helios Albert-Schweitzer-Klinik Northeim
Brief Summary

Adenoma detection rate (ADR) in colon cancer screening is most important for avoiding colon cancer development. Recent studies suggest a benefit of endoscopic devices attached to the distal tip of the colonoscope for improving the ADR. This work is the first GERMAN randomized controlled trial comparing standard colonoscopy with EndoRIngs-assisted colonoscopy.

EndoRings is a new FDA approved device that is attached to the distal tip of the colonoscope. Better Polyp detection is suspected by flattening the mucosal folds during withdrawal

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
225
Inclusion Criteria
  • indication for colonoscopy (screening, surveillance, diagnostic)
  • age ≥ 45 years
  • ability to give informed consent
Exclusion Criteria
  • pregnancy
  • age <45 years
  • known colonic strictures
  • chronic inflammatory bowel disease
  • active inflammation
  • s/p colonic resection
  • bleeding disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
EndoRingsEndoRingsColonoscopy is performed with the EndoRings attached
Standard ColonoscopyStandard colonoscopyStandard colonoscopy without any additional devices
Primary Outcome Measures
NameTimeMethod
Adenoma detection rateduring colonoscopy
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Department of Gastroenterology, University Medical Center

🇩🇪

Göttingen, Lower Saxony, Germany

HELIOS Medical Center Siegburg

🇩🇪

Siegburg, Germany

HELIOS HSK Kliniken

🇩🇪

Wiesbaden, Hessen, Germany

HELIOS St. Marienberg Klinik Helmstedt

🇩🇪

Helmstedt, Germany

Helios Albert-Schweitzer-Hospital, Academic University Teaching Hospital

🇩🇪

Northeim, Germany

© Copyright 2025. All Rights Reserved by MedPath